These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19761164)

  • 1. Aspirin for diabetes: are we adhering to ADA guidelines?
    Aakash ; Sabitha P
    Natl Med J India; 2009; 22(1):49. PubMed ID: 19761164
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin for CV prevention -- for which patients?
    Jackson AN; Hume AL
    J Fam Pract; 2011 Sep; 60(9):518-23. PubMed ID: 21901177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 4. Don't use aspirin for primary prevention of cardiovascular disease.
    Barnett H; Burrill P; Iheanacho I
    BMJ; 2010 Apr; 340():c1805. PubMed ID: 20410163
    [No Abstract]   [Full Text] [Related]  

  • 5. Other studies show aspirin use is high.
    Brown J
    PLoS Med; 2006 Feb; 3(2):e110; author reply e109. PubMed ID: 16492077
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
    Sirois C; Poirier P; Moisan J; Grégoire JP
    Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of type 2 diabetes mellitus: is it in accordance with the guidelines?
    Chan GC; Ghazali O; Khoo EM
    Med J Malaysia; 2005 Dec; 60(5):578-84. PubMed ID: 16515108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylsalicylic acid and diabetes mellitus].
    Paiva S
    Acta Med Port; 2002; 15(3):199-202. PubMed ID: 12379997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American Heart Association Get With The Guidelines program.
    Smaha LA;
    Am Heart J; 2004 Nov; 148(5 Suppl):S46-8. PubMed ID: 15514634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing aspirin use in patients with Type 2 diabetes in the UKPDS.
    Cull CA; Neil HA; Holman RR
    Diabet Med; 2004 Dec; 21(12):1368-71. PubMed ID: 15569143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin for primary prevention in patients with diabetes mellitus.
    Nguyen KX; Marinac JS; Sun C
    Fam Med; 2005 Feb; 37(2):112-7. PubMed ID: 15690251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suggestions made for reducing cardiac drug errors.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Nov; 13(23):1-2, 5. PubMed ID: 12731477
    [No Abstract]   [Full Text] [Related]  

  • 15. The Aspirin Primary Prevention Conundrum.
    Schamroth Pravda M; Schamroth Pravda N; Beigel Y; Matetzky S; Beigel R
    Isr Med Assoc J; 2020 Jan; 22(1):60-63. PubMed ID: 31927808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes care. Defining standards, Part 2.
    Roberts SS
    Diabetes Forecast; 2004 Sep; 57(9):38, 40. PubMed ID: 15457588
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiplatelet therapy for primary and secondary prevention in Jordanian patients with diabetes mellitus.
    Bulatova NR; Yousef AM; AbuRuz SM
    Thromb Res; 2007; 121(1):43-50. PubMed ID: 17462716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Circulation; 2007 Jan; 115(1):114-26. PubMed ID: 17192512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aspirin use in patients with diabetes mellitus].
    Sicras Mainar A; Ruiz Riera R; Frías Garrido X; Navarro Artieda R
    Med Clin (Barc); 2004 Jul; 123(6):237; author reply 239. PubMed ID: 15282081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.